| Recruiting | A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders Hyperphosphatemia Patients on Hemodialysis | Phase 3 | 2026-01-09 |
| Recruiting | A Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment Patients With Mild or Moderate Hepatic Impairment | Phase 1 | 2025-12-23 |
| Recruiting | A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis Hyperphosphatemia Patients on Hemodialysis | Phase 3 | 2025-12-01 |
| Completed | A Pharmacodynamic Study of TS-172 in Healthy Adult Male Subjects Healthy Adult Male Subjects | Phase 1 | 2025-08-05 |
| Completed | An Open-label Pharmacokinetic Study of TS-172 in Patients on Hemodialysis Patients on Hemodialysis | Phase 1 | 2025-03-22 |
| Completed | A Drug-drug Interaction Study With TS-172 in Healthy Adult Male Subjects Healthy Male Subjects | Phase 1 | 2025-03-11 |
| Completed | A QT/QTc Evaluation Study of TS-172 in Healthy Adult Subjects Healthy Volunteers | Phase 1 | 2025-03-03 |
| Completed | A Phase 2 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders Hyperphosphatemia Patients on Hemodialysis | Phase 2 | 2025-01-06 |
| Completed | A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis Hyperphosphatemia Patients on Hemodialysis | Phase 3 | 2025-01-06 |
| Completed | A Mass Balance Study of TS-172 in Healthy Adult Subjects Healthy Male Subjects | Phase 1 | 2024-09-26 |
| Completed | A Study to Investigate the Next-day Residual Effects of TS-142 in Healthy Elderly Subjects Healthy Subjects | Phase 1 | 2023-05-15 |
| Completed | A Food Effect Study of TS-142 in Healthy Subjects Effect of Food | Phase 1 | 2023-02-15 |
| Completed | A Phase 2 Dose-finding Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis Hyperphosphatemia Patients on Hemodialysis | Phase 2 | 2023-02-08 |
| Completed | A Pharmacokinetic Study of TS-142 in Patients with Hepatic Impairment Patients with Mild or Moderate Hepatic Impairment | Phase 1 | 2022-12-26 |
| Completed | Long-Term Study of TS-142 in Patients with Insomnia Patients with Insomnia | Phase 3 | 2022-10-11 |
| Completed | Phase III Study of TS-142 in Patients with Insomnia Patients with Insomnia | Phase 3 | 2022-08-30 |
| Completed | A Phase I Study of TS-172 in Healthy Adult Subjects (Single and Multiple Doses) Healthy Adult Subjects | Phase 1 | 2021-08-16 |
| Completed | A QT/QTc Evaluation Study of TS-142 in Healthy Adult Subjects Healthy Subjects | Phase 1 | 2021-06-07 |
| Completed | Mass Balance Study of TS-142 in Healthy Adult Subjects. Healthy Male Subjects | Phase 1 | 2021-04-19 |
| Completed | A Clinical Pharmacology Study of TS-142 in Patients with Obstructive Sleep Apnea Hypopnea. Patients with Mild Obstructive Sleep Apnea Hypopnea | Phase 1 | 2021-02-24 |
| Completed | A Study to Evaluate Next Day Effects of TS-142 on Driving Performance in Healthy Subjects Healthy Subjects | Phase 1 | 2021-01-16 |
| Completed | Drug-drug Interaction Study with TS-142 in Healthy Adult Subjects (concomitant Administration of Itraconazole) Healthy Subjects | Phase 1 | 2020-10-13 |
| Completed | Late Phase II Study of TS-142 in Patients with Insomnia Patients with Insomnia | Phase 2 | 2020-09-09 |
| Completed | Development and Validation of a Driving Simulator for Evaluating the Residual Effects of Drugs on Driving Perf Healthy Participants | N/A | 2019-10-07 |
| Completed | An Extension Study of TS-152 in Subjects With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 3 | 2019-10-01 |
| Completed | Safety, Pharmacokinetic, and Pharmacodynamic Study of TS-142 in Healthy Subjects Healthy Volunteer | Phase 2 | 2019-09-17 |
| Completed | Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #3 Healthy Participants | N/A | 2018-06-27 |
| Completed | Safety and Efficacy of SFPP in Knee Osteoarthritis Osteoarthritis Knee Pain | Phase 3 | 2018-02-05 |
| Completed | Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #2 Healthy Participants | N/A | 2018-01-22 |
| Completed | A Study to Evaluate the Safety and Efficacy of TS-091 in Patients with Narcolepsy Narcolepsy | Phase 2 | 2017-10-31 |
| Completed | Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #1 Healthy Participants | N/A | 2017-09-22 |
| Completed | Early Phase 2 Clinical Study of TS-142 in Patients with Insomnia Disorder Insomnia Disorder | Phase 2 | 2017-07-07 |
| Completed | Clinical Study of TS-143 in Healthy Adult Male Subjects (Multiple-Dose Administration) Healthy Participants | Phase 1 | 2017-04-03 |
| Completed | Clinical Pharmacology Study of TS-143 in Nondialysis and Hemodialysis Patients With Chronic Kidney Disease Chronic Kidney Disease | Phase 1 | 2016-10-06 |
| Completed | A Phase I Study of TS-142 in Healthy Participants (Repeated Doses) Healthy Volunteer | Phase 1 | 2016-07-06 |
| Completed | Clinical Study of TS-143 in Healthy Adult Male Subjects (Single-Dose Administration) Healthy Participants | Phase 1 | 2015-12-24 |
| Completed | A Phase I Study of TS-142 in Healthy Participants (Single Doses) Healthy Volunteer | Phase 1 | 2015-10-17 |
| Completed | Clinical Study on Histamine H3 Receptor Occupancy of TS-091 by PET Examination in Healthy Adult Subjects Healthy Subjects | Phase 1 | 2014-12-11 |
| Completed | Multiple Dose Safety Study of PF-04802540 in Subjects With Schizophrenia Schizophrenia | Phase 1 | 2009-04-01 |
| Completed | A Study Of The Effect Of PF-04802540 On Sleep Measures Healthy | Phase 1 | 2008-11-01 |
| Completed | Multiple Dose Safety Study of PF-04802540 in Healthy Volunteers Healthy | Phase 1 | 2008-09-01 |